首页|大黄素调节NLRP3/IL-1 β/CXCL1信号通路改善急性呼吸衰竭大鼠炎症反应和肺损伤的实验研究

大黄素调节NLRP3/IL-1 β/CXCL1信号通路改善急性呼吸衰竭大鼠炎症反应和肺损伤的实验研究

扫码查看
目的 探究大黄素对急性呼吸衰竭大鼠炎症反应、肺损伤的影响以及对NOD样受体蛋白3(NLRP3)/白细胞介素-1β(IL-1β)/CXC趋化因子配体1(CXCL1)信号通路的调控作用.方法 支气管滴入大肠杆菌脂多糖构建急性呼吸衰竭大鼠模型,成功造模70只,随机分成模型组,大黄素低(10 mg/kg)、中(20 mg/kg)、高(40 mg/kg)剂量组,大黄素+NLRP3激动剂[40 mg/kg大黄素+10 mg/kg NLRP3激动剂(BMS-986299)]组;每组14只.另取14只健康大鼠以相同方法支气管滴入等量生理盐水设为对照组.各组大鼠以相应方法连续干预7 d(每日1次).肺功能仪和全自动血气分析仪检测大鼠呼吸频率、动脉血二氧化碳分压(PaCO2)、动脉血氧分压(PaO2);酶联免疫吸附法检测肺组织炎症因子[肿瘤坏死因子-α(TNF-α)、白细胞介素-8(IL-8)];苏木素-伊红染色观察肺组织病理学;荧光定量PCR和蛋白印迹法检测肺组织NLRP3、IL-1β、CXCL1信使RNA(mRNA)和蛋白表达.结果 与对照组比较,模型组肺组织结构被破坏,肺泡壁充血,大量炎性细胞浸润,肺泡水肿,呼吸频率、PaCO2及肺组织TNF-α、IL-8、NLRP3、IL-1β、CXCL1 mRNA和蛋白表达显著升高,PaO2显著降低(P<0.05);与模型组比较,大黄素低、中、高剂量组肺组织病变逐渐减轻,肺泡结构逐渐完整,炎性细胞浸润逐渐减少,呼吸频率、PaCO2及肺组织TNF-α、IL-8、NLRP3、IL-1β、CXCL1 mRNA和蛋白表达呈剂量依赖性降低,PaO2呈剂量依赖性升高(P<0.05);大黄素高剂量组比较,大黄素高剂量+NLRP3激动剂组肺组织损伤明显加重,炎性细胞浸润增加,呼吸频率、PaCO2及肺组织TNF-α、IL-8、NLRP3、IL-1β、CXCL1 mRNA和蛋白表达显著升高,PaO2显著降低(P<0.05).结论 大黄素可能通过抑制NLRP3/IL-1β/CXCL1信号通路,改善急性呼吸衰竭大鼠血气指标、炎症反应和肺损伤,发挥对肺的保护作用.
Emodin Modulates NLRP3/IL-1β/CXCL1 Signaling Pathway to Improve Inflammatory Response and Lung Injury in Rats with Acute Respiratory Failure
Objective:To investigate the effects of emodin on inflammatory response and lung injury in rats with acute respiratory failure,as well as its regulatory effect on the NOD like receptor protein 3(NLRP3)/interleu-kin-1β(IL-1 β)/CXC chemokine ligand 1(CXCL1)signaling pathway.Methods:A rat model of acute respiratory failure was constructed by endobronchial infusion of escherichia coli lipopolysaccharide.The 70 successful models were randomly divided into the model group,emodin low(10 mg/kg),medium(20 mg/kg),high(40 mg/kg)dose groups,emodin high dose+NLRP3 agonist[40 mg/kg emodin+10 mg/kg NLRP3 agonist(BMS-986299)]group;14 models in each group.Another 14 healthy rats were set as the control group by bronchial drip with the same amount of normal saline.The rats in each group were continuously treated with the corresponding method for 7 days(once/day).The respiratory rate,arterial partial pressure of carbon dioxide(PaCO2)and arterial partial pres-sure of oxygen(PaO2)of rats were measured by pulmonary function instrument and automatic blood gas analyzer.The inflammatory factors[tumor necrosis factor(TNF-α)and IL-8]in lung tissue were detected by enzyme-linked immunosorbent assay(ELISA).Hematoxylin-eosin(HE)staining was used to observe lung histopathology.The expression of NLRP3,IL-1β,CXCL1 messenger RNA(mRNA)and protein in lung tissue was detected by quantitative PCR and Western blotting.Results:Compared with the control group,the lung tissue structure in the model group was damaged,alveolar walls were congested,there was massive infiltration of inflammatory cells,alveo-lar edema occurred,and respiratory rate,PaCO2,lung tissue TNF-α,IL-8,NLRP3,IL-1β,CXCL1 mRNA,and pro-tein expression significantly increased,while PaO2 significantly decreased(P<0.05);compared with the model group,in the low,medium,and high dose emodin groups,lung tissue lesions gradually alleviated,alveolar struc-tures became increasingly intact,inflammatory cell infiltration gradually decreased,respiratory rate,PaCO2,lung tis-sue TNF-α,IL-8,NLRP3,IL-1 β,CXCL1 mRNA,and protein expression decreased in a dose-dependent manner,while PaO2 increased in a dose-dependent manner(P<0.05);compared with the high dose emodin group,in the high dose emodin+NLRP3 agonist group,lung tissue damage significantly worsened,inflammatory cell infiltration increased,respiratory rate,PaCO2,lung tissue TNF-α,IL-8,NLRP3,IL-1β,CXCL1 mRNA,and protein expression significantly increased,while PaO2 significantly decreased(P<0.05).Conclusion:Emodin may play a protective role on lung by inhibiting NLRP3/IL-1 β/CXCL 1 signaling pathway,improving blood gas index,inflammatory re-sponse and lung injury in rats with acute respiratory failure.

Acute respiratory failureInflammatory responseLung injuryEmodinNOD like receptor protein 3Interleukin-1 βCXC chemokine ligand 1Rats

李梦、陈波、吴娟

展开 >

四川省成都西区医院,四川成都 610036

急性呼吸衰竭 炎症反应 肺损伤 大黄素 NOD样受体蛋白3 白细胞介素-1β CXC趋化因子配体1 大鼠

四川省卫生健康委科研项目

21PJ264

2024

中国中医急症
中华中医药学会

中国中医急症

CSTPCD
影响因子:1.144
ISSN:1004-745X
年,卷(期):2024.33(8)